Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| McMaster University | OTHER |
| Hamilton Health Sciences Corporation | OTHER |
| Weill Medical College of Cornell University | OTHER |
Not provided
Not provided
Not provided
PRINCE is an international, multicentre, randomized controlled trial of posterior pericardiotomy in patients without a history of atrial fibrillation (AF) or flutter undergoing cardiac surgery.
Approximately 30% of cardiac surgical patients develop post-operative atrial fibrillation (POAF). Its incidence varies depending on the type of cardiac operation. POAF is associated with short- and long-term adverse events, including mortality, stroke, and heart failure. POAF has also been significantly associated with unplanned hospitalization for heart failure.
During cardiac surgery, pericardial fluid tends to collect posterior to the left atrium. Even small amounts of fluid may trigger atrial arrhythmias. A posterior left pericardiotomy is a surgical procedure that involves cauterizing an opening between the left inferior pulmonary vein and the diaphragm. This procedure may allow for more prolonged drainage of the pericardial fluid into the left pleural space. Recent research evidence found that posterior pericardiotomy was associated with a significantly lower incidence of POAF.
The existing data on posterior pericardiotomy is promising for a reduction in POAF. However, no high-quality study has demonstrated that this reduction improves clinical outcomes in the years after cardiac surgery. The PRINCE trial's long-term follow-up of patients randomized to left posterior pericardiotomy could conclusively demonstrate whether the relationship of POAF to post-discharge clinical outcomes is causal and modifiable.
The PRINCE trial will evaluate the effectiveness and safety of posterior left pericardiotomy in preventing POAF and improving post-discharge clinical outcomes in a broad spectrum of cardiac surgery patients.
The intervention under investigation is left posterior pericardiotomy which is compared to no posterior pericardiotomy during cardiac surgery. The early co-primary outcome is in-hospital POAF, and the late co-primary outcome is the hierarchical composite of time to all-cause death, time to ischemic stroke, time to systemic arterial embolism, time to unplanned hospital visit/readmission for cardiac reasons, and time to atrial fibrillation after index hospital discharge.
The study will enrol 1400 patients from 30 centres, globally. Follow-up visits will be performed in person or by telephone 1 and 6 months post-randomization (+7 days), and then every 6 months (+30 days) until an average follow-up of 5 years for the study participants (estimated to be 4 years after completion of enrolment).
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Left Posterior Pericardiotomy Group | Experimental | The surgeon will perform a left posterior pericardiotomy during the patient's cardiac surgery. |
|
| No Posterior Pericardiotomy Group | No Intervention | The surgeon will not perform a posterior pericardiotomy during the patient's cardiac surgery. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Left Posterior Pericardiotomy | Procedure | The surgeon will perform a left posterior pericardiotomy while the patient is on cardiopulmonary bypass. A soft channel drain will be put into place at an angle directed toward the posterior pericardium. The surgeon will grasp the pericardium and use cautery to make a 4- to 5-cm opening between the left inferior pulmonary vein and the diaphragm. The previously prepared channel drain is cut to the desired length and placed through the pericardiotomy along the diaphragm and into the pleural space. |
| Measure | Description | Time Frame |
|---|---|---|
| In-hospital post-operative atrial fibrillation | Number of patients with post-operative atrial fibrillation within the first 5 days postoperatively or up to hospital discharge, whichever occurs first | Within 5 days after index cardiac surgery |
| Hierarchical composite of all-cause death, ischemic stroke, systemic arterial embolism, unplanned hospital visit/readmission for cardiac reasons, and atrial fibrillation. | Number of patients with a composite of all-cause death, ischemic stroke, systemic arterial embolism, unplanned hospital visit/readmission for cardiac reasons, and atrial fibrillation events, evaluated using the win ratio (thereby accounting for the difference in importance of these outcomes). | Over the duration of the follow-up period to a common end date (mean follow-up of 5 years). |
| Measure | Description | Time Frame |
|---|---|---|
| Post-operative atrial fibrillation (POAF) | Number of patients with post-operative atrial fibrillation | Over the duration of the follow-up period to a common end date (mean follow-up of 5 years). |
| Length of post-operative in-hospital stay |
| Measure | Description | Time Frame |
|---|---|---|
| Number of patients with phrenic nerve injuries | Safety outcome | Within 30 days of index surgery |
| Number of patients with left pleural interventions | Safety outcome |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Richard Whitlock | Contact | 9055274322 | 40306 | Richard.Whitlock@phri.ca |
| PRINCE Coordinators | Contact | PRINCE@phri.ca |
| Name | Affiliation | Role |
|---|---|---|
| Richard Whitlock | Population Health Research Institute | Principal Investigator |
| Emilie Belley-Côté | Population Health Research Institute | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Weill Cornell Medicine | Recruiting | New York | New York | 10065 | United States |
Not provided
| ID | Term |
|---|---|
| D001281 | Atrial Fibrillation |
| D001282 | Atrial Flutter |
| D002318 | Cardiovascular Diseases |
| ID | Term |
|---|---|
| D001145 | Arrhythmias, Cardiac |
| D006331 | Heart Diseases |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Each patient will be assigned in a blinded fashion to one of two groups (left posterior pericardiotomy or no posterior pericardiotomy) in a 1:1 ratio.
Not provided
Not provided
Blinding to allocation will be maintained for all parties, excluding the operating surgeon and necessary operating room personnel.
|
Length of time the patient in hospital after their index cardiac surgery
| Over the duration of the follow-up period to a common end date (mean follow-up of 5 years). |
| Pericardial effusion without tamponade | Number of pericardial effusions that occur, excluding cardiac tamponade | From index surgery completion to within 30 days of index surgery |
| Death | Occurrence of death | From index surgery completion to within 30 days of index surgery |
| Ischemic stroke or systemic arterial embolism | Number of ischemic strokes or systemic arterial embolisms | From index surgery completion to within 30 days of index surgery |
| Hospital readmission or unplanned hospital visit | Number of hospital readmissions or unplanned hospital visits | From index surgery completion to within 30 days of index surgery |
| Quality of life assessed by the European quality of life index version 5D (EQ-5D-5L) questionnaire | The EQ-5D-5L consists of a descriptive system and the EQ visual analogue scale (EQ VAS) scale of 0-100 where the endpoints are labelled 'The best health you can image' and 'The worst health you can imagine'. The VAS can be used as a quantitative measure of health outcome that reflects the patient's own judgement. The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension is measured on a 5 point scale: no problems, slight problems, moderate problems, severe problems and extreme problems. | Over the duration of the follow-up (mean follow-up of 5 years) |
| Within 30 days of index surgery |
| Number of patients with esophageal injuries | Safety outcome | Within 30 days of index surgery |
| Number of patients requiring re-operation for bleeding | Safety outcome | Within 48 hours of index surgery completion |
| Number of patients with cardiac tamponade | Safety outcome | Within 30 days of index surgery |
| Mario Gaudino |
| Weill Medical College of Cornell University |
| Principal Investigator |
| Sigrid Sandner | Medical University Vienna | Principal Investigator |
| Björn Redfors | Göteborg University | Principal Investigator |
| Medical University Vienna | Recruiting | Vienna | State of Vienna | 1090 | Austria |
|
| Hamilton Health Sciences | Recruiting | Hamilton | Ontario | L8L 2X2 | Canada |
|
| University of Foggia, Policlinico Foggia | Recruiting | Foggia | Foggia | 71122 | Italy |
|